Attitude to Helicobacter pylori infection among Swiss gastroenterologists

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 11, 1999, Pages 441-445

  Binek, J ^a   Fantin, A C ^a   Meyenberger, C ^a  

^a Division of Gastroenterology   (Switzerland)

Author keywords

Attitudes; Helicobacter pylori; Knowledge; Practice; Treatment

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR;

ARTICLE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; MEDICAL SPECIALIST; NORMAL HUMAN; PEPTIC ULCER; PHYSICIAN ATTITUDE; SWITZERLAND;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; DEMOGRAPHY; GASTROENTEROLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERNAL MEDICINE; MIDDLE AGED; PHYSICIANS; QUESTIONNAIRES; SOCIETIES, MEDICAL; SWITZERLAND;

EID: 0033586365     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lee J, O'Morain C. Consensus or confusion: a review of existing national guidelines on Helicobacter pylori-related disease. Eur J Gastroenterol Hepatol 1997;9:527-31.
2. The European Helicobacter Pylori Study Group. Current European concepts in management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997;41: 8-13.
3. Fachgesellschaft der Schweizerischen Gastroenterologen FMH. Helicobacter Krankheiten. Schweiz Ärztezeitung 1996;77:2051-2.
4. Milne R, Logan RPH, Harwood D, Misiewicz JJ, Forman D. Helicobacter pylori and upper gastrointestinal disease: a survey of gastroenterologists in the United Kingdom. Gut 1995; 37:314-8.
5. Breuer T, Goodman KJ, Malaty HM, Sudhop T, Graham DY. How do clinicians practicing in the US manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol 1998;93:553-61.
6. Breuer T, Surdhop T, Goodman KJ, Graham DY, Malfertheiner P. How do practicing clinicians manage Helicobacter pylori-related gastrointestinal diseases in Germany? A survey of gastroenterologists and family practitioners. Helicobacter 1998;3:1-8.
7. Labenz J, Malfertheiner P. Helicobacter pylori - wann und wie behandeln sich Gastroenterologen selbst? Dtsch Med Wochenschr 1997;122:637-42.
8. Fendrick AM, Hirth RA, Chernew ME. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease. Am J Gastroenterol 1996;91:1544-8.
9. NIH consensus Development Panel on Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
10. Talley NJ. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106:1174-83.
11. de Boer WA, Tytgat GNJ. Ninety percent cure: which antiHelicobacter therapy can achieve this treatment goal? Am J Gastroenterol 1995;90:1381-2.
12. Penston JG, McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997;43:223-43.
13. Christensen AH, Logan RPH, Noach A, Gjorup T. Do clinicians accept the role of Helicobacter pylori in duodenal ulcer disease: a survey of European gastroenterologists and general practicioners. J Intern Med 1994;236:501-5.
14. Sieber CC, Frei R, Beglinger C, Mossi S, Binek J, Schaufelberger H, et al. Resistenz von Helicobacter pylori gegen Metronidazol in der Schweiz: Implikationen für die Eradikationstherapie? Schweiz Med Wochenschr 1994;124:1381-4.
15. Heuss LT, Sieber CC, Frei R, Stalder GA, Beglinger C. Resistenzenentwicklung von H. pylori gegen Amoxicillin, Metronidazol und Clarithromycin in der Schweiz 1992-1996. Schweiz Med Wochenschr 1997;127(Suppl 93):36S.
16. de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. Eur J Gastroenterol Hepatol 1996;8:709-16.